Conseco Risk-Based Capital Ratio Benefits Under NAIC Action
22 June 2009 - 10:58PM
PR Newswire (US)
CARMEL, Ind., June 22 /PRNewswire-FirstCall/ -- Conseco, Inc.
(NYSE:CNO) today announced that a recent National Association of
Insurance Commissioners (NAIC) action to modify the mortgage
experience adjustment factor for 2009 will benefit its risk-based
capital ratio. As outlined in Conseco's 2008 Form 10-K filing, its
life insurance subsidiaries are subject to risk-based capital
requirements pursuant to statutory rules and regulations. To
determine the amount of required risk-based capital, the
regulations include a "mortgage experience adjustment factor" that
is applied to the company's entire portfolio of commercial mortgage
loans. At the recently concluded NAIC summer meeting, a proposal to
modify the mortgage experience adjustment factor calculation was
adopted for the year 2009. On a pro-forma basis as of March 31,
2009, the revised calculation reduces the amount of capital
Conseco's insurance subsidiaries are required to hold, increasing
the company's consolidated risk-based capital ratio by more than 25
points. It is our understanding that the Capital Adequacy Task
Force of the NAIC will monitor market conditions and progress on
proposals that may result in modifying or extending the proposal
beyond 2009. There can be no assurance that the short-term
adjustment will continue beyond 2009. About Conseco Conseco, Inc.'s
insurance companies help protect working American families and
seniors from financial adversity: Medicare supplement, long-term
care, cancer, heart/stroke and accident policies protect people
against major unplanned expenses; annuities and life insurance
products help people plan for their financial futures. For more
information, visit Conseco's website at http://www.conseco.com/.
Cautionary Statement Regarding Forward-Looking Statements. Our
statements, trend analyses and other information contained in this
press release relative to markets for Conseco's products and trends
in Conseco's operations or financial results, as well as other
statements, contain forward-looking statements within the meaning
of the federal securities laws and the Private Securities
Litigation Reform Act of 1995. Forward-looking statements typically
are identified by the use of terms such as "anticipate," "believe,"
"plan," "estimate," "expect," "project," "intend," "may," "will,"
"would," "contemplate," "possible," "attempt," "seek," "should,"
"could," "goal," "target," "on track," "comfortable with,"
"optimistic" and similar words, although some forward-looking
statements are expressed differently. You should consider
statements that contain these words carefully because they describe
our expectations, plans, strategies and goals and our beliefs
concerning future business conditions, our results of operations,
financial position, and our business outlook or they state other
'forward-looking' information based on currently available
information. Assumptions and other important factors that could
cause our actual results to differ materially from those
anticipated in our forward-looking statements include, among other
things: (i) general economic, market and political conditions,
including the performance and fluctuations of the financial markets
which may affect our ability to raise capital or refinance existing
indebtedness and the cost of doing so; (ii) our ability to continue
to satisfy the financial ratio and balance requirements and other
covenants of our debt agreements; (iii) our ability to generate
sufficient liquidity to meet our debt service obligations and other
cash needs; (iv) our ability to obtain adequate and timely rate
increases on our supplemental health products including our
long-term care business; (v) the receipt of required regulatory
approvals for dividend and surplus debenture interest payments from
our insurance subsidiaries; (vi) mortality, morbidity, the
increased cost and usage of health care services, persistency, the
adequacy of our previous reserve estimates and other factors which
may affect the profitability of our insurance products; (vii)
changes in our assumptions related to the cost of policies produced
or the value of policies in force at the effective date of our
emergence from bankruptcy; (viii) the recoverability of our
deferred tax asset and the effect of potential tax rate changes on
its value; (ix) changes in accounting principles and the
interpretation thereof; (x) our ability to achieve anticipated
expense reductions and levels of operational efficiencies including
improvements in claims adjudication and continued automation and
rationalization of operating systems, (xi) performance and
valuation of our investments, including the impact of realized
losses (including other-than-temporary impairment charges); (xii)
our ability to identify products and markets in which we can
compete effectively against competitors with greater market share,
higher ratings, greater financial resources and stronger brand
recognition; (xiii) the ultimate outcome of lawsuits filed against
us and other legal and regulatory proceedings to which we are
subject; (xiv) our ability to complete the remediation of the
material weakness in internal controls over our actuarial reporting
process and to maintain effective controls over financial
reporting; (xv) our ability to continue to recruit and retain
productive agents and distribution partners and customer response
to new products, distribution channels and marketing initiatives;
(xvi) our ability to achieve eventual upgrades of the financial
strength ratings of Conseco and our insurance company subsidiaries
as well as the potential impact of ratings downgrades on our
business; (xvii) the risk factors or uncertainties listed from time
to time in our filings with the Securities and Exchange Commission;
(xviii) regulatory changes or actions, including those relating to
regulation of the financial affairs of our insurance companies,
such as the payment of dividends and surplus debenture interest to
us, regulation of financial services affecting (among other things)
bank sales and underwriting of insurance products, regulation of
the sale, underwriting and pricing of products, and health care
regulation affecting health insurance products; and (xix) changes
in the Federal income tax laws and regulations which may affect or
eliminate the relative tax advantages of some of our products.
Other factors and assumptions not identified above are also
relevant to the forward-looking statements, and if they prove
incorrect, could also cause actual results to differ materially
from those projected. All written or oral forward-looking
statements attributable to us are expressly qualified in their
entirety by the foregoing cautionary statement. Our forward-looking
statements speak only as of the date made. We assume no obligation
to update or to publicly announce the results of any revisions to
any of the forward-looking statements to reflect actual results,
future events or developments, changes in assumptions or changes in
other factors affecting the forward-looking statements. DATASOURCE:
Conseco, Inc. CONTACT: (News Media) Tony Zehnder, EVP, Corporate
Communications +1-312-396-7086, (Investors) Scott Galovic, Senior
Director, Investor Relations, +1-317-817-3228, both of Conseco,
Inc. Web Site: http://www.conseco.com/
Copyright